Cover Image
市場調查報告書

疼痛管理設備的全球市場預測 2021年:神經刺激、SCS (脊髓刺激療法) 、TENS (經皮末梢神經電刺激) 、RF切除、輸液幫浦

Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 359793
出版日期 內容資訊 英文 200 Pages
訂單完成後即時交付
價格
Back to Top
疼痛管理設備的全球市場預測 2021年:神經刺激、SCS (脊髓刺激療法) 、TENS (經皮末梢神經電刺激) 、RF切除、輸液幫浦 Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021
出版日期: 2016年06月09日 內容資訊: 英文 200 Pages
簡介

全球疼痛管理設備市場,預計從2016年2021年之間以8.5%的年複合成長率擴大,到2021年達到46億4,000萬美元。該市場的成長主要由於巨大患者族群的存在及止痛劑的利用伴隨的副作用等要素索推進。可是,疼痛管理設備的可用性及利用相關認識低,疼痛專家的不足,及好幾個國家的疼痛門診少,抑制疼痛管理設備市場成長。

本報告提供全球疼痛管理設備市場相關調查,市場趨勢,產業概要及市場影響因素分析,各種類、應用、購買形態、地區的目前市場需求與預測,及主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球疼痛管理設備市場概要
  • 全球疼痛管理設備市場地區概要
  • 全球疼痛管理設備市場:各應用、地區
  • 全球疼痛管理設備市場:各購買形態、地區

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推進因素
    • 阻礙要素
    • 機會
    • 課題

第6章 產業考察

  • 簡介
  • 產業趨勢
    • 穿戴式設備
    • 疼痛管理設備市場上整合
    • 充電式脊髓電刺激設備廣受歡迎
  • 波特的五力分析

第7章 全球疼痛管理設備市場:各類型

  • 簡介
  • 神經刺激設備
    • 經皮末梢神經電刺激 (TENS) 設備
    • 脊髓刺激療法 (SCS) 設備
  • 止痛藥輸注泵
    • 髓腔內輸液幫浦
    • 外部輸液幫浦
  • 切除設備
    • RF切除設備
    • 冷凍切除設備

第8章 全球疼痛管理設備市場:各應用領域

  • 簡介
  • 神經性疼痛
  • 癌症性疼痛
  • 臉痛、偏頭痛
  • 肌肉骨骼疼痛
  • 其他應用

第9章 全球疼痛管理設備市場:各購買形態

  • 簡介
  • OTC疼痛管理設備
  • 處方箋為基礎疼痛管理設備

第10章 疼痛管理設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 全球其他地區

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形及趨勢

第12章 企業簡介 (概要、財務、產品 & 服務、策略及發展趨勢)

  • 簡介
  • MEDTRONIC PLC
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • HOSPIRA, INC. (A SUBSIDIARY OF PFIZER INC.)
  • HALYARD HEALTH, INC.
  • SMITHS MEDICAL
  • B. BRAUN MELSUNGEN AG
  • NEUROTECH NA, INC. (A SUBSIDIARY OF THERAGEN LLC)
  • BECTON, DICKINSON AND COMPANY
  • NEVRO CORP.

第13章 附錄

圖表

目錄
Product Code: MD 4371

The global pain management devices market is estimated to grow at a CAGR of 8.5% from 2016 to 2021 to reach USD 4.64 billion by 2021. Growth in this market is primarily driven by factors such as the presence of a large patient population base and adverse effects associated with the use of pain medications. However, factors such as low awareness regarding the availability and use of pain management devices, shortage of pain specialists, and low number of pain clinics in several countries are restraining the growth of this market.

The global pain management devices market has been segmented on the basis of type (neurostimulation devices, ablation devices, and analgesic infusion pumps), applications (neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others), mode of purchase (over-the-counter and prescription-based pain management devices), and region (North America, Europe, Asia-Pacific, and Rest of the World).

The neurostimulation devices market is estimated to witness the highest growth and account for the largest share of the global pain management devices market, by type, in 2016. Geographically, North America is expected to command the largest share of the global pain management devices market in 2016, followed by Europe. The growth in the North American market is primarily driven by various factors, including the presence of an established government reimbursement scenario for SCS devices and the large number of ongoing clinical trials in this region.

As of 2015, the global pain management devices market was dominated by Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), which together accounted for more than 50% of the market. New product launches, partnerships, agreements, and collaborations are the major strategies adopted by market players to strengthen their presence and increase their share in the pain management devices market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis, market share analysis of top ten players, and detailed company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth market segments, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information of pain management devices offered by the top 10 market players. The report analyzes the pain management devices market by type of product, mode of purchase, and application across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pain management devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pain management devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the pain management devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
    • 1.4.1. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
      • 2.2.1.2. Primary research
      • 2.2.1.3. Key data from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
    • 2.3.2. RESEARCH METHODOLOGY: TOP-DOWN APPROACH
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY
  • 2.7. LIMITATIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL PAIN MANAGEMENT DEVICES MARKET OVERVIEW (2016-2021)
  • 4.2. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL PAIN MANAGEMENT DEVICES MARKET
  • 4.3. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AND REGION (2016)
  • 4.4. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE AND REGION (2016 VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing demand for long-term pain management among the geriatric population
      • 5.3.1.2. Large patient population base
      • 5.3.1.3. Adverse effects of pain medications
      • 5.3.1.4. High proven efficacy of pain management devices for the treatment of chronic pain
      • 5.3.1.5. Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries
      • 5.3.1.6. Development of novel pain management devices
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Low awareness about the availability and use of pain management devices
      • 5.3.2.2. Shortage of pain specialists and low number of pain clinics in several countries
      • 5.3.2.3. Existence of a gap in prevalence and treatment of pain
      • 5.3.2.4. High procedural and purchase cost of pain management devices
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Increasing number of patients suffering from neuropathic pain
      • 5.3.3.2. Expanding base of pain management clinics/centers across the globe
      • 5.3.3.3. Strong product pipeline for pain management devices
      • 5.3.3.4. Stringent regulations to limit opioid pain killer prescriptions
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Presence of alternative therapies for pain management
      • 5.3.4.2. Use of pain medications as the first line of treatment for pain management
      • 5.3.4.3. Stringent regulatory guidelines delay the adoption of novel devices

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. WEARABLE DEVICES
    • 6.2.2. CONSOLIDATION IN THE PAIN MANAGEMENT DEVICES MARKET
    • 6.2.3. RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS
  • 6.3. PORTER'S FIVE FORCES ANALYSIS
    • 6.3.1. THREAT OF NEW ENTRANTS
    • 6.3.2. THREAT OF SUBSTITUTES
    • 6.3.3. BARGAINING POWER OF SUPPLIERS
    • 6.3.4. BARGAINING POWER OF BUYERS
    • 6.3.5. INTENSITY OF COMPETITIVE RIVALRY

7. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. NEUROSTIMULATION DEVICES
    • 7.2.1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
      • 7.2.1.1. Introduction of advanced & wearable TENS devices
    • 7.2.2. SPINAL CORD STIMULATION (SCS) DEVICES
      • 7.2.2.1. Cost benefits of SCS over other therapies
  • 7.3. ANALGESIC INFUSION PUMPS
      • 7.3.1.1. High use of infusion pumps in post-operative pain management
    • 7.3.2. INTRATHECAL INFUSION PUMPS
    • 7.3.3. EXTERNAL INFUSION PUMPS
  • 7.4. ABLATION DEVICES
    • 7.4.1. RF ABLATION DEVICES
    • 7.4.2. CRYOABLATION DEVICES

8. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. NEUROPATHIC PAIN
    • 8.2.1. HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN
  • 8.3. CANCER PAIN
  • 8.4. FACIAL PAIN & MIGRAINE
  • 8.5. MUSCULOSKELETAL PAIN
  • 8.6. OTHER APPLICATIONS

9. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

  • 9.1. INTRODUCTION
  • 9.2. OVER-THE-COUNTER PAIN MANAGEMENT DEVICES
    • 9.2.1. OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES
  • 9.3. PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES

10. PAIN MANAGEMENT DEVICES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Rising geriatric population in the U.S.
      • 10.2.1.2. Rising patient population base
      • 10.2.1.3. High demand of pain management devices for the treatment of post-operative pain
      • 10.2.1.4. Large number of ongoing clinical trials
      • 10.2.1.5. Favorable reimbursement scenario for SCS
      • 10.2.1.6. Stringent regulatory policies
      • 10.2.1.7. Lack of reimbursement for TENS in the U.S.
    • 10.2.2. CANADA
      • 10.2.2.1. Reduced healthcare spending
      • 10.2.2.2. Rising prevalence of chronic disorders
  • 10.3. EUROPE
    • 10.3.1. RISING AGING POPULATION IN EUROPE
    • 10.3.2. HUGE PATIENT POPULATION BASE
    • 10.3.3. CONFERENCES TO INCREASE AWARENESS OF PAIN MANAGEMENT DEVICES IN THE EUROPEAN MARKET
    • 10.3.4. NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS
    • 10.3.5. ORGANIZATION OF CAMPAIGNS TO RAISE AWARENESS ABOUT PAIN MANAGEMENT APPROACHES
    • 10.3.6. SLOW ECONOMIC GROWTH IN EUROPE
    • 10.3.7. CHANGING REGULATORY POLICIES
    • 10.3.8. LIMITED AWARENESS OF NEW PAIN MANAGEMENT APPROACHES
    • 10.3.9. GERMANY
      • 10.3.9.1. Large number of ongoing clinical trials
      • 10.3.9.2. Rising aging population and cancer incidence
      • 10.3.9.3. Favorable healthcare reimbursement scenario
    • 10.3.10. FRANCE
      • 10.3.10.1. Rising adoption of pain management devices due to increased patient population
      • 10.3.10.2. Availability of proper healthcare facilities, training, and reimbursement for pain management therapies
    • 10.3.11. U.K.
      • 10.3.11.1. Large patient population base
      • 10.3.11.2. Rising healthcare expenditure
      • 10.3.11.3. Presence of noteworthy number of organizations related to pain management
      • 10.3.11.4. Availability of funding for research in pain management
      • 10.3.11.5. Government recommendations encouraging use of SCS
      • 10.3.11.6. Safety issues related to infusion pumps
      • 10.3.11.7. Low penetration of pain management devices in the country
    • 10.3.12. ROE
      • 10.3.12.1. Growing patient population
      • 10.3.12.2. Rapidly increasing aging population in the region
      • 10.3.12.3. Growing preference towards home use pain management devices
      • 10.3.12.4. Key factors hampering market growth
  • 10.4. ASIA-PACIFIC
    • 10.4.1. LARGE PATIENT POPULATION WITH CANCER, DIABETES, AND CHRONIC PAIN
    • 10.4.2. IMPROVING HEALTHCARE INFRASTRUCTURE IN ASIAN COUNTRIES
    • 10.4.3. JAPAN
      • 10.4.3.1. Growing patient base
      • 10.4.3.2. Increase in the baby boomer population
      • 10.4.3.3. Well-developed healthcare system
      • 10.4.3.4. Inflow of advanced pain management devices
      • 10.4.3.5. Rising government focus towards the development of the medical devices industry
      • 10.4.3.6. Pricing and reimbursement challenges for foreign suppliers
    • 10.4.4. CHINA
      • 10.4.4.1. Growing diabetic population
      • 10.4.4.2. Increasing disposable income and healthcare spending
      • 10.4.4.3. Extensive use of traditional Chinese medicine (TCM) for alleviating pain
      • 10.4.4.4. Uncertain and changing regulatory environment
    • 10.4.5. INDIA
      • 10.4.5.1. Huge addressable market
      • 10.4.5.2. Growing number of pain management centers
      • 10.4.5.3. Rising focus of global players
      • 10.4.5.4. Growing demand for pain management devices
      • 10.4.5.5. Conferences and meetings on neuromodulation & pain management in India
      • 10.4.5.6. Rising government support
      • 10.4.5.7. High dependence of patients on low-cost generic medicine
      • 10.4.5.8. Key factors limiting the growth of the Indian pain management devices market
    • 10.4.6. REST OF ASIA-PACIFIC
      • 10.4.6.1. South Korea presents significant opportunities for pain management devices in Asia
      • 10.4.6.2. Large number of conferences in Australia
      • 10.4.6.3. Ongoing product innovations in Singapore & Australia
  • 10.5. REST OF THE WORLD
    • 10.5.1. INCREASING INCIDENCES OF CANCER IN LATIN AMERICA
    • 10.5.2. AGING POPULATION
    • 10.5.3. STRICT REGULATIONS ON MEDICAL DEVICES IN BRAZIL

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
    • 11.2.1. KEY PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS
    • 11.3.2. AGREEMENTS, ALLIANCES, AND CONTRACTS
    • 11.3.3. GEOGRAPHICAL EXPANSIONS
    • 11.3.4. MERGERS & ACQUISITIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 12.1. INTRODUCTION
  • 12.2. MEDTRONIC PLC
  • 12.3. ST. JUDE MEDICAL, INC.
  • 12.4. BOSTON SCIENTIFIC CORPORATION
  • 12.5. HOSPIRA, INC. (A SUBSIDIARY OF PFIZER INC.)
  • 12.6. HALYARD HEALTH, INC.
  • 12.7. SMITHS MEDICAL
  • 12.8. B. BRAUN MELSUNGEN AG
  • 12.9. NEUROTECH NA, INC. (A SUBSIDIARY OF THERAGEN LLC)
  • 12.10. BECTON, DICKINSON AND COMPANY
  • 12.11. NEVRO CORP.

*Details might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: ACCESS TO INTERDISCIPLINARY PAIN MANAGEMENT SERVICES IN DIFFERENT COUNTRIES, 2012
  • TABLE 2: GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 4: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021(USD MILLION)
  • TABLE 5: NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 6: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 7: SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 8: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021(USD MILLION)
  • TABLE 9: ANALGESIC INFUSION PUMPS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 10: INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 11: EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 12: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021(USD MILLION)
  • TABLE 13: ABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 14: RF ABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 15: CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 16: GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 17: NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 23: OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 33: U.S.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: U.S.: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: U.S.: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 36: U.S.: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 39: CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: CANADA: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 52: GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: GERMANY: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 57: GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 58: FRANCE : PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: FRANCE : NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE : ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: FRANCE : ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: FRANCE : PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 63: FRANCE : PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 64: U.K.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: U.K.: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: U.K.: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: U.K.: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: U.K.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 69: U.K.: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 70: ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: ROE: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 75: ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: ASIA-PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: ASIA-PACIFIC: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: ASIA-PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 83: JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: JAPAN: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 88: JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 89: CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: CHINA: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 94: CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 95: INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: INDIA: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 100: INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 101: REST OF ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: REST OF ASIA-PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: REST OF ASIA-PACIFIC: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: REST OF ASIA-PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: REST OF ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: REST OF ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 107: REST OF WORLD: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: REST OF WORLD: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: REST OF WORLD: ANALGESIC INFUSION PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: REST OF WORLD: ABLATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: REST OF WORLD: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 112: REST OF WORLD: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 113: NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012-2016
  • TABLE 114: AGREEMENTS, ALLIANCES, AND CONTRACTS , 2012-2016
  • TABLE 115: GEOGRAPHICAL EXPANSIONS, 2012-2016
  • TABLE 116: MERGERS & ACQUISITIONS, 2012-2016
  • TABLE 117: OTHER DEVELOPMENTS, 2012-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL PAIN MANAGEMENT DEVICES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 5: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE (2016 VS. 2021)
  • FIGURE 6: PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION (2016 VS. 2021)
  • FIGURE 7: PAIN MANAGEMENT DEVICES MARKET SHARE, BY MODE OF PURCHASE (2016 VS. 2021)
  • FIGURE 8: GEOGRAPHICAL SNAPSHOT OF THE PAIN MANAGEMENT DEVICES MARKET, 2016
  • FIGURE 9: GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION-PRIMARY MARKET DRIVER
  • FIGURE 10: APAC IS THE MOST LUCRATIVE REGION FOR MARKET PLAYERS
  • FIGURE 11: U.S. TO COMMAND THE LARGEST SHARE OF THE PAIN MANAGEMENT DEVICES MARKET IN 2016
  • FIGURE 12: PRESCRIPTION-BASED SEGMENT TO DOMINATE THE PAIN MANAGEMENT DEVICES MARKET IN 2021
  • FIGURE 13: PAIN MANAGEMENT DEVICES MARKET SEGMENTATION
  • FIGURE 14: GLOBAL PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: PREVALENCE OF CHRONIC PAIN, BY AGE, 2011
  • FIGURE 16: IMPACT OF CHRONIC PAIN IN THE U.S.: CHRONIC PAIN AFFECTS MORE PEOPLE THAN DIABETES, HEART DISEASE, AND CANCER COMBINED
  • FIGURE 17: STRONG COMPETITIVE LANDSCAPING OF PAIN MANAGEMENT DEVICES OVER OTHER PRODUCTS
  • FIGURE 18: EXPANDING PATIENT POPULATION BASE DRIVING MARKET GROWTH
  • FIGURE 19: AWARENESS OF SPINAL CORD STIMULATION FOR PAIN MANAGEMENT IN EUROPE, 2013
  • FIGURE 20: LOW AWARENESS REGARDING THE AVAILABILITY AND USE OF PAIN MANAGEMENT DEVICES IS A MAJOR FACTOR RESTRAINING MARKET GROWTH
  • FIGURE 21: ESTIMATED TOTAL ADDRESSABLE MARKET POTENTIAL FOR NEUROPATHIC PAIN MANAGEMENT DEVICES AMONG DIABETIC PATIENTS, 2015
  • FIGURE 22: INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROPATHIC PAIN TO OFFER NEW GROWTH OPPORTUNITIES TO MARKET PLAYERS
  • FIGURE 23: PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE
  • FIGURE 24: PORTER'S FIVE FORCES ANALYSIS (2016): PRESENCE OF A LARGE NUMBER OF MANUFACTURING FIRMS INCREASES COMPETITION
  • FIGURE 25: NEUROSTIMULATION DEVICES SEGMENT IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL PAIN MANAGEMENT DEVICES MARKET
  • FIGURE 26: NEUROPATHIC PAIN SEGMENT TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 27: OVER-THE-COUNTER SEGMENT TO WITNESS HIGHER GROWTH DURING THE FORECAST PERIOD OF 2016 TO 2021
  • FIGURE 28: PAIN MANAGEMENT DEVICES MARKET: GROWTH FORECAST, BY REGION (2016-2021)
  • FIGURE 29: NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 30: ASIA-PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 31: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2016
  • FIGURE 32: GLOBAL PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 33: NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 34: GEOGRAPHIC REVENUE MIX OF THE TOP MARKET PLAYERS (2015)
  • FIGURE 35: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 36: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 37: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: HOSPIRA, INC.: COMPANY SNAPSHOT
  • FIGURE 39: HALYARD HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 40: SMITHS MEDICAL: COMPANY SNAPSHOT
  • FIGURE 41: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 42: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 43: NEVRO CORP.: COMPANY SNAPSHOT
Back to Top